Abbott LaboratoriesABTNYSE
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 34,608 | 43,075↑24.5% | 43,653↑1.3% | 40,109↓8.1% | 41,950↑4.6% |
| Cost Of Revenue | 17,231 | 19,861↑15.3% | 21,330↑7.4% | 20,072↓5.9% | 20,625↑2.8% |
| Gross Profit | 17,377 | 23,214↑33.6% | 22,323↓3.8% | 20,037↓10.2% | 21,325↑6.4% |
| Operating Expenses | 12,086 | 14,014↑16.0% | 13,961↓0.4% | 13,602↓2.6% | 14,474↑6.4% |
| Operating Income | 5,291 | 9,200↑73.9% | 8,362↓9.1% | 6,435↓23.0% | 6,825↑6.1% |
| Interest Expense | 708 | 410↓42.1% | 315↓23.2% | 698↑121.6% | 603↓13.6% |
| Income Before Tax | 4,968 | 8,211↑65.3% | 8,306↑1.2% | 6,664↓19.8% | 7,013↑5.2% |
| Income Tax Expense | 497 | 1,140↑129.4% | 1,373↑20.4% | 941↓31.5% | -6,389↓779.0% |
| Net Income | 4,495 | 7,071↑57.3% | 6,933↓2.0% | 5,723↓17.5% | 13,402↑134.2% |
| EBITDA | 9,003 | 12,159↑35.1% | 11,888↓2.2% | 10,605↓10.8% | 10,834↑2.2% |
| EPS | 2.52 | 3.97↑57.5% | 3.94↓0.8% | 3.30↓16.2% | 7.67↑132.4% |
| EPS Diluted | 2.50 | 3.94↑57.6% | 3.91↓0.8% | 3.27↓16.4% | 7.64↑133.6% |